Expression of EpCAMMFand EpCAMMTvariants in human carcinomas

EpCAM proteolysis: new fragments with distinct functions?

(2013) Ulrike Schnell et al.   BIOSCIENCE REPORTS

EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2+, basal-like and HER2 intrinsic subtypes of breast cancer

(2013) S D Soysal et al.   BRITISH JOURNAL OF CANCER

Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma

(2012) Tada Kunavisarut et al.   BMC CANCER

Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines

(2012) Agnieszka Martowicz et al.   BMC CANCER

Epithelial cell adhesion molecule is an independent prognostic marker in clear cell renal carcinoma

(2012) Christian Eichelberg et al.   INTERNATIONAL JOURNAL OF CANCER

Cytoplasmic Trop-1/Ep-CAM Overexpression is Associated with a Favorable Outcome in Node-positive Breast Cancer

(2012) Saverio Alberti et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Epithelial Cell Adhesion Molecule Regulates Tumor Initiation and Tumorigenesis via Activating Reprogramming Factors and Epithelial-Mesenchymal Transition Gene Expression in Colon Cancer

(2012) Cheng-Wei Lin et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Effects of EpCAM overexpression on human breast cancer cell lines

(2011) Johanna M Gostner et al.   BMC CANCER

Documenting the Natural History of Patients With Resected Stage II Adenocarcinoma of the Colon After Random Assignment to Adjuvant Treatment With Edrecolomab or Observation: Results From CALGB 9581

(2011) Donna Niedzwiecki et al.   JOURNAL OF CLINICAL ONCOLOGY

EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis

(2011) Gilbert Spizzo et al.   JOURNAL OF CLINICAL PATHOLOGY

Stromal interaction molecule 2 (STIM2) is frequently overexpressed in colorectal tumors and confers a tumor cell growth suppressor phenotype

(2011) Alvaro Aytes et al.   MOLECULAR CARCINOGENESIS

Impact of the EpCAM expression on biochemical recurrence-free survival in clinically localized prostate cancer

(2011) Goran Benko et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

EpCAM nuclear localization identifies aggressive Thyroid Cancer and is a marker for poor prognosis

(2010) Ranju Ralhan et al.   BMC CANCER

Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM×anti-CD3) as a targeted cancer immunotherapy

(2010) Diane Seimetz et al.   CANCER TREATMENT REVIEWS

Nuclear and Cytoplasmic Accumulation of Ep-ICD Is Frequently Detected in Human Epithelial Cancers

(2010) Ranju Ralhan et al.   PLoS One

EpCAM: Another Surface-to-Nucleus Missile

(2009) Graham Carpenter et al.   CANCER CELL

Nuclear signalling by tumour-associated antigen EpCAM

(2009) Dorothea Maetzel et al.   NATURE CELL BIOLOGY

MOC-31 Exhibits Superior Reactivity Compared With Ber-EP4 in Invasive Lobular and Ductal Carcinoma of the Breast

(2009) Reetesh K. Pai et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY